Wednesday, January 23, 2013
Jonathan Thomas, chairman of the California stem cell agency, presented the following plan today to the governing board of the agency to deal with recommendations of the Institute of Medicine. Sphere: Related Content
With more than one million page views and more than 4,000 items, this blog provides news and commentary on public policy, business and economic issues related to the $3 billion California stem cell agency, officially known as the California Institute for Regenerative Medicine(CIRM). David Jensen, a retired California newsman, has published this blog since January 2005. His email address is email@example.com.
StemCells, Inc. stock price performance -- Google chart Highlights Layoffs, clinical trial closed Conflicts of interest Implications...